sera – Page 55 – Communicable Diseases Research

Evaluation of the performance of SARS‐CoV‐2 antibody assays for a longitudinal populationbased study of COVID‐19 spread in St. Petersburg, Russia

Research Article

Published on 2021-06-122022-10-04
Journal: Journal of medical virology [Category] MERS, SARS, 진단, 치료기술,

[키워드] 95% CI 95%CI Abbott acute respiratory syndrome antibody antibody assay Antibody test antibody test result Architect AUC binding antibody calculated Characteristics clinical CMIA Concordance coronavirus correlated COVID19 Cutoff diagnostic ELISA gold standard IgG immunoassay Immunoglobulin immunosorbent Local majority measure median time Microneutralization test Microparticle MNA neutralizing antibody participant PCR polymerase chain positive positive individuals positive PCR test receiver operating characteristics robust Russia Saint Petersburg SARS‐CoV‐2 SARSCoV2 SARSCoV2 infection antibody testing sensitivity sera seroepidemiologic study serological shown specificity Spread threshold total antibody Variation virus neutralization test
[DOI] 10.1002/jmv.27126 PMC 바로가기 [Article Type] Research Article

Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods

다양한 혈청학적 방법을 통한 SARS-CoV-2 특이 항체 반응의 종단적 검출

Comparative Study

Published on 2021-06-112022-09-10
Journal: Journal of medical virology [Category] MERS, SARS, 진단, 치료기술, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus analyzed antibodies antibody Antibody Response Antigen antigens assays Blood donors cells children collected Concentration coronavirus coronavirus disease Coronavirus disease 2019 COVID‐19 COVID‐19 detect diagnostic eight ELISA ELISAs healthy blood donors highest IgA IgG IgM immunofluorescence Immunoglobulin immunoglobulin A Immunoglobulin G immunoglobulin M immunosorbent indirect immunofluorescence individual infections information Kinetics longitudinal Patient peaked polymerase chain polymerase chain reaction Prevalence Protein provided respiratory S1 domain SARS‐CoV‐2 SARS‐CoV‐2‐infected SARS‐CoV‐2 seasonal coronaviruses selected sensitivities sensitivity sera serological serological assays Serological testing serology serum sample serum samples specific antibodies specific antibody specificity Spike protein substrate symptom onset tested the viral nucleocapsid Viral viral nucleocapsid protein virus
[DOI] 10.1002/jmv.27113 PMC 바로가기 [Article Type] Comparative Study

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

Research

Published on 2021-06-102022-10-05
Journal: Nature [Category] SARS, 변종, 임상,

Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2

어린 유아는 SARS-CoV-2에 대한 강력한 기능적 항체 반응과 억제된 IFN-γ 생산을 나타냅니다.

Comparative Study

Published on 2021-06-092022-09-12
Journal: Cell Reports Medicine [Category] MERS, 진단,

Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections

COVID-19 환자 또는 박테리아 및 비 SARS-CoV-2 바이러스 호흡기 감염 환자에서 4가지 SARS-CoV-2 항체 분석의 진단 성능

Comparative Study

Published on 2021-06-092022-09-10
Journal: European Journal of Clinical Microbiology & Infect [Category] MERS, SARS, 진단, 치료기술,

[키워드] anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody assays Bacterial bacterial and viral infections Bacterial infection Bacterial infections bacterial respiratory infections benefit Cell Chlamydia Control coronavirus COVID-19 COVID-19 patients cross-reactivity disease ELISA ELISAs enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays epidemiological studies Epidemiological study Euroimmun Evidence evidence of expressing false-positive result fatal disease highest IgA IgG Interpretation Legionella pneumophila Mycoplasma pneumoniae Patient patients with COVID-19 pneumoniae positive respiratory Respiratory disease respiratory infections SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 spike protein sensitivity sera serological evidence Specificities specificity Spike protein supplementary material T cells the SARS-CoV-2 vaccine response vaccine responses Viral viral infection viral infections viral respiratory viral respiratory infection Vircell vulnerable patients
[DOI] 10.1007/s10096-021-04285-4 PMC 바로가기 [Article Type] Comparative Study

Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection

무증상 또는 경증 감염이 있는 해병 모집단의 발병 후 SARS-CoV-2에 대한 항체 반응

Immunology

Published on 2021-06-092022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 진단, 치료기술, 치료법,

[키워드] Adults age antibodies Asymptomatic asymptomatic infection Betacoronavirus circulating Cohort comparable COVID-19 cross-reactivity disease domain Endemic enrolled focus healthy Humoral response humoral responses IgA antibodies IgA antibody IgG IgG antibodies IgG antibody Infection investigated Longitudinal studies longitudinal study Mild Mild disease mild SARS-CoV-2 infection mild symptoms Multiplex assay neutralization activity Neutralizing activity no decrease nucleocapsid outbreak participant polyclonal Population positive positive correlation Protein RBD recruit remained reported respiratory Respiratory illness response S protein S proteins SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 RBD SARS-CoV-2 spike sera serological response significantly spring tested young adults zoonotic
[DOI] 10.3389/fimmu.2021.681586 PMC 바로가기 [Article Type] Immunology

A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel

Brief Report

Published on 2021-06-082022-10-28
Journal: Vaccines [Category] COVID-19,

Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay

Article

Published on 2021-06-072022-10-28
Journal: Vaccines [Category] COVID-19,

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

Article

Published on 2021-06-072022-10-04
Journal: Nature [Category] Fulltext, SARS, 변종, 유전자 메커니즘,

[키워드] anti-RBD antibodies antibody antigenic Antimicrobial responses B.1.1.7 B.1.351 Brazil caused circumvent cloned conserved coronavirus COVID-19 COVID-19 mortality COVID-19 pandemic death domain E484K Efficacy Emergency use authorization epitope Evolution expressed homotrimers Immunotherapy inaccessible Infectious diseases mice multivalent mutant mutations N501Y nanobodies nanobody neutralization activity neutralize Neutralizing new SARS-CoV-2 not neutralize overcome P.1 Patient Prevent produced RBD RBD region recognize recognizing SARS-CoV-2 SARS-CoV-2 mutation SARS-CoV-2 variant sera South Africa substitutions the receptor-binding domain two group Vaccine variant viral escape virus
[DOI] 10.1038/s41586-021-03676-z PMC 바로가기 [Article Type] Article

Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva

Research Article

Published on 2021-06-072022-10-28
Journal: Pathogens and Immunity [Category] COVID-19,